Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 276 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

276 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 276 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

276 programs

Clinical programs

Page 4 of 6

  1. Soticlestat

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    4 trials

  2. Soticlestat 300 mg

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. TAK-004

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. TAK-007

    Takeda

    Refractory Lupus Nephritis

    phase 1 mab terminated

    1 trial

  5. TAK-020

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. TAK-020 Captisol Oral Solution

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  7. TAK-058

    Takeda

    Schizophrenia

    phase 1 small molecule terminated

    1 trial

  8. TAK-058

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  9. TAK-058 (ENV8058)

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  10. TAK-063

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  11. TAK-063

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. TAK-071

    Takeda

    Alzheimer Disease

    phase 1 small molecule terminated

    1 trial

  13. TAK-079

    Takeda

    Autoimmune Disease

    phase 1 small molecule completed

    1 trial

  14. TAK-079

    Takeda

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  15. TAK-079

    Takeda

    Systemic Lupus Erythematosus

    phase 1 small molecule completed

    1 trial

  16. TAK-079-1006

    Takeda

    IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)

    phase 1 other active

    1 trial

  17. TAK-102

    Takeda

    Solid Tumors

    phase 1 mab terminated

    1 trial

  18. TAK-103

    Takeda

    Solid Tumors

    phase 1 mab terminated

    1 trial

  19. TAK-105-a

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. TAK-114 10 mg capsule

    Takeda

    Clinical Pharmacology

    phase 1 small molecule completed

    1 trial

  21. TAK-117

    Takeda

    Metastatic Solid Tumors

    phase 1 small molecule completed

    1 trial

  22. TAK-117

    Takeda

    Neoplasm, Advanced or Metastatic

    phase 1 small molecule completed

    1 trial

  23. TAK-123

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. TAK-137

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    phase 1 small molecule terminated

    1 trial

  25. TAK-137

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  26. TAK-137 5 mg tablet, TAK-137 placebo tablet

    Takeda

    Healthy Japanese Adult Male

    phase 1 small molecule terminated

    1 trial

  27. TAK-164

    Takeda

    Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies

    phase 1 small molecule terminated

    1 trial

  28. TAK-165

    Takeda

    Breast Neoplasm

    phase 1 small molecule completed

    1 trial

  29. TAK-227

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. TAK-228

    Takeda

    Advanced Nonhematologic Malignancies

    phase 1 small molecule completed

    1 trial

  31. TAK-233

    Takeda

    Clinical Pharmacology

    phase 1 small molecule completed

    1 trial

  32. TAK-272

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial

  33. TAK-272

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  34. TAK-279

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  35. TAK-279

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  36. TAK-279

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  37. TAK-329

    Takeda

    Type 1 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  38. TAK-385

    Takeda

    Hormone Treatment-naïve Participants With Prostate Cancer

    phase 1 small molecule completed

    1 trial

  39. TAK-385 40 mg

    Takeda

    Japanese Premenopausal Healthy Adult Women

    phase 1 small molecule completed

    1 trial

  40. TAK-385 T2 Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  41. TAK-418

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    2 trials

  42. TAK-418

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  43. TAK-438

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    2 trials

  44. TAK-438

    Takeda

    Erosive Esophagitis(EE)

    phase 1 small molecule completed

    1 trial

  45. TAK-438

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  46. TAK-438

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  47. TAK-438

    Takeda

    Ascending Single Dose Study

    phase 1 small molecule completed

    1 trial

  48. TAK-438 OD

    Takeda

    Japanese Healthy Adult Male

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

276 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.